Search Results for: POLA2

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
FGFR3 fibroblast growth factor receptor 3
  • Signaling by activated point mutants of FGFR3
  • FGFR3 mutant receptor activation
  • t(4;14) translocations of FGFR3
  • Signaling by FGFR3 fusions in cancer
  • Signaling by FGFR3 point mutants in cancer
  • XL999
  • Pazopanib
  • Ponatinib
  • Lenvatinib
  • Nintedanib
  • Fostamatinib
  • Erdafitinib
  • Pemigatinib
  • Selpercatinib
  • Bladder cancer
  • Multiple myeloma
  • Lacrimo-auriculo-dento-digital syndrome (LADD); Levy-Hollister syndrome
  • Craniosynostosis, including: Pfeiffer syndrome; Apert syndrome; Crouzon syndrome; Jackson-Weiss syndrome; Beare-Stevenson syndrome; Muenke craniosynostosis; Saethre-Chotzen syndrome; Craniosynostosis Boston type; Antley-Bixler syndrome; Carpenter syndrome; Craniofrontonasal dysplasia; Noonan syndrome; Baller-Gerold syndrome
  • FGFR3-related short limb skeletal dysplasias, including: Achondroplasia; Hypochondroplasia; Thanatophoric dysplasia, type 1; Thanatophoric dysplasia, type 2; Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN)
  • CATSHL syndrome
FRZB frizzled related protein
HDAC6 histone deacetylase 6
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • HSF1 activation
  • Notch-HLH transcription pathway
  • Cilium Assembly
  • Transcriptional regulation by RUNX2
  • RUNX2 regulates osteoblast differentiation
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Vorinostat
  • Belinostat
  • Pracinostat
  • Romidepsin
  • Panobinostat
  • Bufexamac
HELB DNA helicase B
HGH1 HGH1 homolog
IGFBP3 insulin like growth factor binding protein 3
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • TP53 Regulates Transcription of Death Receptors and Ligands
  • Post-translational protein phosphorylation
  • Alitretinoin
  • Mecasermin
KCNE3 potassium voltage-gated channel subfamily E regulatory subunit 3
  • Phase 3 - rapid repolarisation
  • Phase 2 - plateau phase
  • Enflurane
  • Promethazine
  • Miconazole
  • Brugada syndrome (BRS)
KLF6 Kruppel like factor 6
LRPAP1 LDL receptor related protein associated protein 1
MFHAS1 malignant fibrous histiocytoma amplified sequence 1
NR4A1 nuclear receptor subfamily 4 group A member 1
  • AKT phosphorylates targets in the nucleus
  • Nuclear Receptor transcription pathway
  • Constitutive Signaling by AKT1 E17K in Cancer
PARP1 poly(ADP-ribose) polymerase 1
  • POLB-Dependent Long Patch Base Excision Repair
  • vRNA Synthesis
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SUMOylation of DNA damage response and repair proteins
  • HDR through MMEJ (alt-NHEJ)
  • DNA Damage Recognition in GG-NER
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER
  • Theophylline
  • Zinc
  • Carba-nicotinamide-adenine-dinucleotide
  • NU1025
  • Nicotinamide
  • 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
  • 3-Methoxybenzamide
  • 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
  • 3,4-Dihydro-5-Methyl-Isoquinolinone
  • 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide
  • 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
  • Veliparib
  • A-620223
  • 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
  • Olaparib
  • Talazoparib
  • Niraparib
  • Rucaparib
  • Iniparib
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
POLA1 DNA polymerase alpha 1, catalytic subunit
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Polymerase switching on the C-strand of the telomere
  • Telomere C-strand synthesis initiation
  • DNA replication initiation
  • Activation of the pre-replicative complex
  • Polymerase switching
  • Removal of the Flap Intermediate
  • Processive synthesis on the lagging strand
  • G1/S-Specific Transcription
  • Cladribine
  • Clofarabine
  • Fludarabine
  • Nelarabine
PRIM2 DNA primase subunit 2
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Polymerase switching on the C-strand of the telomere
  • Telomere C-strand synthesis initiation
  • DNA replication initiation
  • Activation of the pre-replicative complex
  • Polymerase switching
  • Removal of the Flap Intermediate
  • Processive synthesis on the lagging strand
PRPF38A pre-mRNA processing factor 38A
  • mRNA Splicing - Major Pathway
RBM23 RNA binding motif protein 23
SETDB1 SET domain bifurcated histone lysine methyltransferase 1
  • PKMTs methylate histone lysines
SNU13 small nuclear ribonucleoprotein 13
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • (S)-3-phenyllactic acid
  • Anisomycin
STK40 serine/threonine kinase 40
ULK2 unc-51 like autophagy activating kinase 2
  • Fostamatinib

Page 2 out of 3 pages